HCW Biologics Inc. (HCWB) — Institutional Holders, Q2 2026
12 institutional investment managers reported a HCWB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $515.7K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
HCWB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPAdded · +49,782 sh+$248.4K
- CITADEL ADVISORSAdded · +15,595 sh+$77.8K
- VANGUARD FIDUCIARYAdded · +6,193 sh+$30.9K
- Connective Capital ManagementNew · +3,338 sh+$16.7K
- Tower Research Capital (TRC)Added · +1,644 sh+$8.2K
Biggest sellers
- HRT FINANCIALTrimmed · -30,816 sh-$153.8K
- Virtu FinancialSold out · -7,968 sh-$39.8K
- GEODE CAPITAL MANAGEMENTSold out · -5,981 sh-$29.8K
- CITIGROUPSold out · -1,755 sh-$8.8K
- UBS Group AGTrimmed · -1,536 sh-$7.7K
HCWB 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 52,138 sh | 52,138 | $260.2K | 0.00% | +268.9% |
| 2 | CITADEL ADVISORS#2 · 19,942 sh | 19,942 | $99.5K | 0.00% | -23.5% |
| 3 | HRT FINANCIAL#3 · 13,583 sh | 13,583 | $67.0K | <0.01% | -94.9% |
| 4 | VANGUARD FIDUCIARY#4 · 6,510 sh | 6,510 | $32.5K | 0.00% | +242.1% |
| 5 | Tower Research Capital (TRC)#5 · 4,117 sh | 4,117 | $20.5K | <0.01% | -72.3% |
| 6 | Connective Capital Management#6 · 3,338 sh | 3,338 | $16.7K | 0.01% | New |
| 7 | VANGUARD CAPITAL MANAGEMENT#7 · 2,003 sh | 2,003 | $10.0K | 0.00% | -83.3% |
| 8 | Golden State Wealth Management#8 · 1,667 sh | 1,667 | $8.3K | <0.01% | -83.3% |
| 9 | BARCLAYS PLC#9 · 191 sh | 191 | $953.00 | 0.00% | New |
| 10 | OSAIC#10 · 4 sh | 4 | $20.00 | 0.00% | -84.6% |
| 11 | Caitong International Asset Management , Ltd#11 · 11 sh | 11 | $10.00 | 0.00% | New |
| 12 | UBS Group AG#12 · 1 sh | 1 | $5.00 | 0.00% | -100.0% |
Funds that sold out of HCWB in Q2 2026 (6)
Held HCWB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Virtu Financial7,968 sh | 7,968 | $17.0K |
| GEODE CAPITAL MANAGEMENT5,981 sh | 5,981 | $12.9K |
| CITIGROUP1,755 sh | 1,755 | $3.8K |
| WELLS FARGO & COMPANY167 sh | 167 | $360.00 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT0 sh | 0 | $1.00 |
| SBI Securities , Ltd.0 sh | 0 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.